Cargando…
Mesenchymal stem cell therapy: A review of clinical trials for multiple sclerosis
Multiple sclerosis (MS) is a disease of the central nervous system (CNS) that is the result of the body's own immune cells being auto-reactive to the myelin regions of the body as if these regions were foreign antigens. This demyelination process is damaging to the electrical conductivity of ne...
Autores principales: | Alanazi, Asma, Alassiri, Mohammad, Jawdat, Dunia, Almalik, Yaser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420954/ https://www.ncbi.nlm.nih.gov/pubmed/36092509 http://dx.doi.org/10.1016/j.reth.2022.07.003 |
Ejemplares similares
-
Mesenchymal stem cells in multiple
sclerosis - translation to clinical trials
por: Dulamea, A
Publicado: (2015) -
The Perspectives of Mesenchymal Stem Cell Therapy in the Treatment of Multiple Sclerosis
por: Naderi, Nima
Publicado: (2015) -
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
por: Uccelli, Antonio, et al.
Publicado: (2019) -
Mesenchymal Stem Cells and Induced Pluripotent Stem Cells as Therapies for Multiple Sclerosis
por: Xiao, Juan, et al.
Publicado: (2015) -
Mesenchymal Stem Cell Therapy in Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Islam, Md Asiful, et al.
Publicado: (2023)